Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What FDA Interchangeable Biosimilar Designation Requires and Which Products Have Achieved It Under Section 351(k) of the Public Health Service Act, a biosimilar can receive interchangeable designation if it meets biosimilarity criteria and demonstrates, via switching studies, that alternating between the biosimilar and the reference product produces no greater safety or efficacy risk than continued use of the reference product
But the best drug is not always the one with the biggest number
Clinical trials showed A1c reductions of ~0.8%1.0% with albiglutide, a bit less than other GLP-1 RAs, but still significant
Placing vials directly against frozen gel packs or dry ice may expose them to temperatures lower than intended
She takes metformin for diabetes
Understanding these molecular targets provides clinicians with insight into BPC-157's broad therapeutic potential across tissue types
